The Air Liquide group firm is accelerating its investments in biotechnologies. Seppic has opened a laboratory devoted to fermentation on the group’s Innovation Campus Delaware, the place Seppic’s American Buyer Technical Service Heart has been primarily based since 2007.
Fermentation is a course of traditionally used to supply and protect meals. Utilized to the cosmetics and well being markets, this know-how allows the manufacturing of biobased components with restricted affect on the setting and biodiversity, whereas minimizing affect on land use.
“With new gear and in depth know-how, the intention of this laboratory can be to develop new components that mix efficacy with a response to societal challenges within the cosmetics and well being fields, consistent with the corporate’s method to dedicated innovation,” mentioned the corporate in a press release.
With this alternative of location, Seppic goals to learn from robust synergies with Air Liquide Group R&D actions on the Campus, in addition to with the dynamic American Analysis ecosystem within the subject of biotechnologies.
“Following the opening in 2024 of recent Analysis amenities at our Castres web site in France, Seppic continues to speculate sooner or later with this laboratory in america. It should allow us to proceed innovating for the efficiency of our components by addressing the wants of our markets,” mentioned Hannes Moeller, Chief Govt Officer of Seppic.